Genetic and phenotypic studies on the strains biochemically identified as Shewanella putrefaciens, which had a G+C content ranging from 52 to 54 mol% were conducted. The moles percent G+C of the type strain of S. putrefaciens is 46. Surprisingly, DNA homology experiments revealed that all these strains are genetically related to Shewanella d g a (which was reported to produce tetrodotoxin), not to the type strain of S. putrefaciens. In this study, we reidentified clinical strains of S. putrefaciens which have a high range of moles percent G+C, as does S. alga. We also characterized the reidentified strains and found that the original description of S. alga (U. Simidu, K. Kita-Tsukamoto, T. Yasumoto, and M. Yotsu, Int. J. Syst. Bacteriol.
on the basis of the physiological characterization of 35 additional strains.
S. alga is known to be a tetrodotoxin (lTX)-producing bacterium (25, 26) . Production of TTX by some newly reidentified strains was examined. This is the first report of 'ITX production by strains isolated from human clinical specimens. putrefaciens isolated from different human clinical specimens were provided by several researchers in Japan (Table  1) . We also isolated 32 strains of S. putrefaciens from pond water, sewage, foods, soil, and the skin of animals and used them to find physiological traits distinguishing S. putrefaciens from S. alga. Six of these strains were used for DNA-DNA hybridization experiments.
MATERIALS AND METHODS

Strains used and isolation
The primary step of isolation was performed in an aerobic environment by selective growth in peptone solution containing 1% peptone (Difco Laboratories, Detroit, Mich.), 1% NaC1, and 0.1% bile salts (Difco). Nonfermentative, hydrogen sulfide-producing colonies were selected on deoxycholate-hydrogen sulfide-lactose (DHL) agar (Eiken Chemical Co., Ltd., Tokyo, Japan). Isolates were finally identified as S. putrefaciens by additional biochemical tests described in the Manual of Clinical Microbiology (7).
Physiological tests. Physiological tests were performed by the methods described in the Manual of Clinical Microbiology (7), except for those tests described below. Lecithinase and lipase activities were detected by the methods of Stenstrom et al. (28) , and P-galactosidase was detected as de- scribed by Smibert and Krieg (27) . The medium developed by Wood and Baird (30) was used to determine reduction of trimethylamine oxide. Trimethylamine production after 2 days of incubation at 30°C was examined by the method of Laycock and Reiger (12) . Growth temperatures were tested on nutrient agar plates (Difco) supplemented with 1.5% NaCl for 7 days at 37 or 42°C and for 14 days at 4°C. Tolerance to NaCl was determined visually after 48 h of vigorous shaking in nutrient broth (Difco) supplemented with 6% NaCl at 30°C. Hemolysis was determined from sheep blood agar plates (Eiken Chemical Co., Ltd.) incubated at 30 or 37°C for 2 days. Flagellar staining was performed as described by Heimbrook et al. (8) .
Determination of G+C content of DNA. Ten micrograms of the denatured DNA was hydrolyzed with P1 nuclease (50 Fg/ml in 50 mM acetate buffer containing 0.1 mM ZnC1, [pH 5.31 ; Yamasa S h o p Co., Ltd., Chiba, Japan) for 2 h at 50°C. Then, 2.4 x lo-, U of alkaline phosphatase (Takara Shuzo Co., Ltd., Tokyo, Japan) was added, and the mixture was incubated at 37°C for 1 h. Separation and quantification of nucleosides were performed with high-performance liquid chromatography (HPLC) system LC-6A (Shimadzu Co., Ltd., Kyoto, Japan) and a Cosmosil 5c18 column (Nakarai Tesque Co., Ltd., Kyoto, Japan). The nucleosides were eluted with a solvent system of 0.2 M NH,H,PO,acetonitrile (20: 1 [vol/vol] ).
DNA-DNA homology experiment. The method of fluorometric hybridization using biotin-labelled DNA was described previously (5). DNA-DNA hybridization was carried out in 50% formamide solution at 37°C for 180 min.
Analysis of TTX and its derivatives. Each strain was cultured in 400 ml of L medium, which contains 0.5% polypeptone (Nihon Pharmaceutical Co., Ltd.), 0.1% yeast extract (Difco Laboratories), 1% NaCl, 0.2% KCl, and 0.4% MgS04 . 7H20. After incubation for 18 h at 20"C, cells were harvested by centrifugation at 16,000 x g , and then the toxins were extracted from cells and culture medium.
After the cells were washed with 0.3 M NaCl solution, they were suspended in 0.1% acetic acid, subsequently ultrasonicated, and boiled for 20 min. The extract was centrifuged at 25,000 x g for 20 min, and then the supernatant was purified using a SEP-PAK C,, cartridge (Waters Associates). The eluate was evaporated to dryness, and the residue was dissolved in a small amount of distilled water.
The culture medium was acidified to pH 3.5 with acetic acid, boiled for 20 min, and evaporated to dryness. The residue was extracted three times with methanol containing 1% acetic acid. After evaporation to dryness, the residue was dissolved in distilled water. The solution was further purified by passage through a charcoal column and a SEP-PAK c 1 8 cartridge. The eluate was evaporated to dryness, and the residue was dissolved in a small amount of distilled water.
Ion-paired reverse-phase HPLC was used to separate and detect TTX and its derivatives in the extracts (31) . A JUSCO Tri Roter-VI chromatograph (Japan Spectroscopic Co., Ltd., Tokyo, Japan) with a Senshu Pak ODs-3251-D column (Senshu Scientific Co.) was used for HPLC. For detecting fluorescence, the excitation and emission wavelengths were set at 365 and 510 nm, respectively, on a Hitachi FlOOO fluorescence spectrophotometer . The tissue culture bioassay (11) was performed for the determination and quantitative measurement of sodium channel-blocking toxin in the samples.
RESULTS
DNA base composition. The moles percent G+C values of the strains examined in this study are shown in Table 1 . The G+C content of the S. putrefaciens type strain (IAM 1207gT) was 46 mol%. The moles percent G+C of IAM 13614, IAM 13615, and P-hemolytic clinical strains (which were biochemically identified as S. putrefaciens) were distinctly higher and ranged from 52 to 54. The results indicate that these clinical strains and two IAM strains are clearly different from IAM 1207gT but are quite similar to S. alga with regard to their G+C content, because the G+C content of the S. alga type strain (IAM 14159=) was reported to be 54 mol% (26) .
The G+C content of the nonhemolytic strains, including IAM 12079=, IAM 13595, and some of the clinical strains and newly isolated environmental strains all ranged from 45 to 48 mol%.
DNA-DNA homology. DNA relatedness between S. alga IAM 1415gT and S. putrefaciens strains was examined ( (Table 3) (Table 4) . A clear single peak corresponding to 4-epi-tetrodotoxin (4-epi-TTX) was detected in each cell extract (Fig. 1) . TTX and anhydrotetrodotoxin (anh-TTX) were detected in culture medium, but, the peaks corresponding to these two compounds were very small and unclear. Additional experiments using tissue culture assay (Table 4) showed the presence of significant levels of sodium channelblocking toxin in both cells and culture medium for two strains (TPH 519 and SH 8764) or in either the cells or culture medium for two strains (IAM 13615 and JH 122) . 
DISCUSSION
Since the first report by King on clinical isolates of S. putrefaciens ( l o ) , the strains were conventionally identified by the following characteristics: nonfermentative, gramnegative, rod shaped, oxidase positive, hydrogen sulfide production. However, heterogeneity of the species was pointed out by many researchers ( 2 , 7 , 1 3 , 1 4 , 18,20, 21,23,  24, 28) , especially the remarkable differences between clinical and environmental isolates. One of the reasons why taxonomic study of these isolates had not been done was the difficulty in collecting strains from human clinical specimens, because S. putrefaciens infections in humans are rare.
We obtained 40 strains individually isolated from human clinical specimens during the period of 1978 to 1991 in Japan. Studies of the characteristics of these strains led us to the findings that 33 of these strains were P-hemolytic and had apparently higher moles percent G + C values than that of the type strain of S. putrefaciens. Taxonomic studies on S. putrefaciens strains, including the type strain, some IAM strains, and newly isolated clinical and environmental strains, were then performed. The results showed that all clinical strains that have 52 to 54 mol% G+C belong to S. alga, not to S. putrefaciens.
The type strain of S. alga (IAM 14159=), which was isolated from red algae is reported to be a TTX-producing marine bacterium (25, 26). We showed that four clinical strains identified as S. alga in this study produced 4-epi-TTX 
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- and might release TTX or anh-'ITX into the culture medium.
The results of tissue culture assay which is used for detection of the sodium-channel blocking activity of TTX also support the production of TTX and its derivatives by these strains.
On the basis of 35 strains genetically identified as S. alga, we clarified the physiological differences between S. alga and S. putrefaciens as presented in Table 5 . Thus, we propose the emended description of S. alga given below.
Emended description of Shewanella alga (Simidu, KitaTsukamoto, Yasumoto, and Yotsu 1990). Cells are gramnegative, straight short rods and have polar flagella. They grow in 6% NaCl, on Salmonella-Shigella agar, and at 42"C, but not at 4°C. Colonies become yellow-orange or brown after 2 days of incubation at 37°C. Reduction of trimethylamine oxide reaction is positive. All strains produce hydrogen sulfide, indophenol oxidase, ornithine decarboxylase, gelatinase, DNase, lecithinase, and lipase. Acids are produced by oxidation from D-ribose, but not from D-arabinose, L-arabinose, D-mannose, mannitol, iso-inositol, L-rhamnose, D-xylose, sucrose, maltose, and D-lactose. Acid production from D-glucose is variable. They exhibit hemolysis on sheep blood agar and are pathogenic to humans. The G+C content of the DNA is 52 to 54 mol%. Production of tetrodotoxin and its derivatives is confirmed by the type strain (IAM 14159') (25, 26) and some clinical strains.
The species can be differentiated from S. putrefaciens by the following characteristics: growth at 42"C, in 6% NaCl, and on Salmonella-Shigella agar, hemolysis on sheep blood agar, acid production from D-ribose but not from L-arabinose.
The type strain is IAM 14159 (OK-1; Simidu et al., 1990) .
The moles percent G+C of the type strain is 54 (Simidu et al., 1990) . Conclusions. Thus, we reidentified the strains of S. putrefaciens which have 52 to 54 mol% G+C as S. alga. However, the question remains as to whether or not S. alga belongs to the genus Shewanella, because S. alga is the only species in the genus that has a high moles percent G+C. Analysis of part of the sequence of 16s rRNA of S. alga showed that this strain is more closely related to S. putrefaciens than to species in the Pseudomonas or Alteromonas genus (26) . Comparative study of the full sequence of 16s rRNA with other strains in the Shewanella genus is needed to confirm the taxonomic situation of S. alga.
At the same time, we found at least three DNA homology groups within the strains which have 45 to 48 mol% G+C. Similar findings for the S. putrefaciens strains have been reported by several researchers (14, 20, 23, 28) . At present, however, we could not find significant traits to differentiate these homology groups. A new classification of S. putrefaciens should be proposed in the near future after significant characteristics distinguishing between the different DNA homology groups are found.
